TURN THERAPEUTICS INCTTRX

Bearish

ASignal's systematic analysis rates TTRX as Bearish.

Reflects the latest available analysis · analyzed Oct 11, 2026

The case on TTRX

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • RSI near oversold level (32.08), potentially indicating downside exhaustion
  • Price trading below 20-day SMA and Bollinger Middle Band, suggesting possible mean reversion opportunity
  • Cash position exceeds total debt ($10.29M vs $6.12M), providing runway for operations
VS
Bear case
  • Negative MACD histogram and MACD below signal line indicate bearish momentum
  • Negative price momentum (-0.0798) and trading below 20-day EMA suggest ongoing downtrend
  • Extremely high price-to-book ratio (521.74x) and negative ROE (-686.28%) reflect poor capital efficiency
  • Negative operating cash flow ($-4.32M) despite positive free cash flow, raising sustainability concerns
  • Debt-to-equity ratio of 8.91x is highly leveraged, increasing financial risk
  • Lack of revenue and earnings growth data (N/A) limits fundamental visibility
Subscriber-only

See the full verdict on TTRX

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes TTRX

Most investors never get a second opinion, let alone several. ASignal runs TTRX past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

TURN THERAPEUTICS INC (TTRX) Stock Analysis - ASignal rates it Bearish